Phaeochromocytoma in a Malignant Hyperthermia Patient under Anaesthesia

Hartley L. , Perry-Keene D. Phaeochromocytoma in Queensland — 1970–83. Aust NZ J Surg 1985; 55: 471–475.

St John Sutton M.G. , Sheps S.G. , Lie J.T. Prevalence of clinically unsuspected phaeochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 1981; 56: 354–360.

Hume D.M. Phaeochromocytoma in the adult and child. Am J Surg 1960; 99: 458–496.

Sellevold O.F.M. , Raeder J. , Stenseth R. Undiagnosed phaeochromocytoma in the perioperative period. Case reports. Acta Anaesthesiol Scand 1985; 29: 474–479.

Badui E. , Mancilla R. , Szymanski J.J. , Garcia-Rubi D. , Estanol B. Diverse clinical manifestations of phaeochromocytomas. Angiology 1982 Mar 33(3): 173–82.

Landsberg L. , Young J.B. Phaeochromocytoma. In: Harrison's Principles of Internal Medicine, 11th Ed, McGraw Hill 1988; pp 1775–78.

The European Malignant Hyperpyrexia Group. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 1984; 56: 1267–69.

Britt B.A. , Kalow W. Malignant hyperthermia: A statistical review. Can Anaesth Soc J 1970; 17: 293.

Hull C.J. Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthesia management. Br J Anaesth 1986; 58: 1453–1468.

Crowley K.J. , Cunningham A.J. , Conroy B. , O'Connell P.R. , Collins P.G. Phaeochromocytoma — a presentation mimicking malignant hyperthermia. Case report. Anaesthesia 1988; 43(12): 1031–2.

Addonizio G. , Susman V. Neurolept malignant syndrome and the use of anesthetic agents. Letter. Am J Psych 1986; 143(1): 127–8.

Hughes E.W. , Hodkinson B.P. Carcinoid syndrome: The combined use of ketanserin and octreotide in the management of an acute crisis during anaesthesia. Anaesth Intens Care 1989; 17: 367–70.

Chapin J.W. Asystole after IV dantrolene in pigs. Anesthesiology 1981; 54: 527–8.

Roizen M.F. Diseases of The Endocrine System. In: Anaesthesia and Uncommon Diseases. Katz , Benumof , Kadis eds, 3rd Ed. Saunders, 1990.

Samuels M.A. Neurogenic heart disease: a unifying hypothesis. Am J Cardiol 1987 Dec; 60(18): 15J–19J.

Tammisto T. , Jaattela A. , Nikki P. , Takki S. Effect of pentazocine and pethidine on plasma catecholamine levels. Ann Clin Res 1971; 3: 22–29.

Lawrence C.A. Pethidine induced hypertension in phaeochromocytoma. Br Med J 1978; 1: 149–150.

Plouin P.F. , Menard J. , Corvol P. Hypertensive crisis in a patient with phaeochromocytoma given metoclopramide. Letter. Lancet 1976; ii: 1357–58.

Bittar D.A. Innovar-induced hypertensive crisis in patients with phaeochromocytoma. Anesthesiology 1979; 50: 366–69.

Sumikawa K. , Amakata Y. The pressor effect of droperidol on a patient with phaeochromocytoma. Anesthesiology 1977; 46: 359–361.

Sumikawa K. , Hirano H. , Amakata Y. , Kashimoto T. , Wada A. , Izumi F. Mechanism of the effect of droperidol to induce catecholamine efflux from the adrenal medulla. Anesthesiology 1985; 62: 17.

Desmonts J.M. , Marty J. Anaesthetic management of patients with phaeochromocytoma. Br J Anaesth 1984; 56: 781–89.

Cousins M.J. , Rubin R.B. The intra-operative management of phaeochromocytoma with total epidural sympathetic blockade. Br J Anaesth 1974; 46: 78.